Advertisement

Quality Control of Radiopharmaceuticals

  • Gopal B. Saha

Abstract

Since radiopharmaceuticals are intended for human administration, it is imperative that they undergo strict quality control measures. Basically, quality control involves several specific tests and measurements that ensure the purity, potency, product identity, biologic safety, and efficacy of radiopharmaceuticals. All quality control procedures that are applied to nonradioactive pharmaceuticals are equally applicable to radiopharmaceuticals; in addition, tests for radionuclidic and radiochemical purity have to be carried out. Often these quality control tests are carried out by the manufacturers from the beginning of production all the way up to the finished product. However, the introduction of kits, the increasing use of short-lived radionuclides such as 99mTc and 113mIn, and the on-site preparation of many radiopharmaceuticals require that most, if not all, quality control tests be performed on all in-house preparations before dispensing these agents for human administration.

Keywords

High Performance Liquid Chromatography High Performance Liquid Chromatography Radiochemical Purity High Performance Liquid Chromatography Method Limulus Amebocyte Lysate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Avis KE. Parenteral preparations. In: Remington’s Pharmaceutical Sciences. 16th ed, Easton, Mack; Pa: 1980:1463.Google Scholar
  2. Billinghurst MW. Chromatographic quality control of 99mTc-labeled compounds. J Nucl Med .1973; 14:793.PubMedGoogle Scholar
  3. Bobinet DD, Williams GC, Cohen MB. Comparison of commercial pyrogen testing laboratories. Am J Hosp Pharm 1976; 33 : 801.PubMedGoogle Scholar
  4. Chandler RP. A micro-thin-layer chromatography method for radiopharmaceuticals. Appl Radiol 1977; 6: 216.Google Scholar
  5. Dewanjee MK. The chemistry of 99mTc-labeled radiopharmaceuticals. Semin Nucl Med. 1990; 20: 5.PubMedCrossRefGoogle Scholar
  6. Eckelman WC, Levenson SM, Johnston GS. Radiochemical purity of 99mTcradiopharmaceuticals. Appl Radiol 1977; 6 : 211.Google Scholar
  7. Guideline on validation of the Limulus Amebocyte Lysate test as an end-product endotoxin test for human and animal parenteral drugs, biological products, and medical devices. U.S. FDA, Rockville, Md; 1987.Google Scholar
  8. Krogsgaard OW. Radiochemical purity of various 99mTc-labelled bone-scanning agents. Eur J Nucl Med. 1976; 1 : 15.PubMedGoogle Scholar
  9. Pauwels EKJ, Feitsma RIJ. Radiochemical quality control of 99mTc-labeled radiopharmaceuticals. Eur J Nucl Med. 1977; 2 : 97.PubMedCrossRefGoogle Scholar
  10. Rhodes BA, ed. Quality control in nuclear medicine. St Louis: Mosby; 1977.Google Scholar
  11. Robbins PJ. Chromatography of technetium 99mTc-radiopharmaceuticals—a practical guide. New York: Society of Nuclear Medicine, Inc; 1984.Google Scholar
  12. Stelmach HA, Quinn IL. Radiopharmaceutical quality control. Semin Nucl Med. 1974; 4: 295.PubMedCrossRefGoogle Scholar
  13. Subramanian G, Rhodes BA, Cooper JF, Sodd VJ, eds. Radiopharmaceuticals. New York: Society of Nuclear Medicine; 1975.Google Scholar
  14. Tubis M. Quality control of radiopharmaceuticals. In: Rocha AFG, Harbert JC, eds. Textbook of Nuclear Medicine: Basic Science. Philadelphia: Lea & Febiger; 1978 : 234.Google Scholar
  15. U.S. Pharmacopeia XXII United States Pharmacopeial Convention, Rockville, Md: 1990.Google Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Gopal B. Saha
    • 1
  1. 1.Department of Nuclear MedicineThe Cleveland Clinic FoundationClevelandUSA

Personalised recommendations